Keyphrases
Ningbo China
100%
Multidrug-resistant Mycobacterium Tuberculosis
100%
Molecular Characterization
100%
Phenotypic Characterization
100%
Pyrazinamide
100%
Pyrazinamide Resistance
100%
Ningbo
36%
PncA Gene
36%
DNA Sequencing
27%
Tuberculosis Patients
27%
Drug Resistance
18%
Drug Susceptibility Testing
18%
Beijing Strain
18%
Mycobacterium Tuberculosis (M. tb)
18%
Susceptible Groups
18%
China
9%
Point mutation
9%
Treatment Outcome
9%
Rapid Detection
9%
MDR Strains
9%
Tuberculosis Dispensary
9%
Streptomycin
9%
Background Detection
9%
Molecular Characteristics
9%
Prevalence Characteristics
9%
PncA
9%
Ethambutol
9%
Resistant Isolate
9%
Ofloxacin
9%
Mycobacterium Tuberculosis Strains
9%
Levofloxacin
9%
Medicine and Dentistry
Mycobacterium Tuberculosis
100%
Pyrazinamide
100%
DNA Sequence
16%
Prevalence
11%
Drug Resistance
11%
Drug Sensitivity
11%
Sensitivity and Specificity
5%
Genotype
5%
Ethambutol
5%
Ofloxacin
5%
Point Mutation
5%
Streptomycin
5%
Levofloxacin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pyrazinamide
100%
Mycobacterium Tuberculosis
100%
Prevalence
11%
Drug Resistance
11%
Ofloxacin
5%
Streptomycin
5%
Levofloxacin
5%
Ethambutol
5%
Biochemistry, Genetics and Molecular Biology
Mycobacterium Tuberculosis
100%
DNA Sequence
25%
Prevalence
16%
Drug Resistance
16%
Drug Sensitivity
16%
Genotyping
8%
Levofloxacin
8%
Point Mutation
8%
Ofloxacin
8%
Streptomycin
8%
Immunology and Microbiology
Mycobacterium Tuberculosis
100%
DNA Sequence
25%
Prevalence
16%
Drug Resistance
16%
Drug Sensitivity
16%
Point Mutation
8%
Genotype
8%